The genome engineering company took its overall funding to approximately $50m in a series B round that included property developer Alexandria Real Estate Equities.
US-based genome engineering technology developer Synthego raised $41m in series B funding yesterday from investors including life science real estate developer Alexandria Real Estate Equities.
Venture capital firm 8VC led the round, which included AME Cloud Ventures, Elements Capital, OS Fund, ZhenFund, Founders Fund, Menlo Ventures, WI Harper Group, SciFi VC and angel investors Jennifer Doudna and Jamie H Doudna Cate.
Synthego is developing synthetic RNA molecules that can be used for Crispr genome editing and research. It plans to…
